Skip to main content

FDA acts to encourage generic competition for complex drugs

By Denver Post / Associated Press  
   October 03, 2017

The U.S. Food and Drug Administration is opening a new front in its efforts to reduce high drug prices by encouraging development of generic versions of hard-to-make medicines.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.